Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,929 | 45,586 | 56,563 | 64,547 | 41,717 |
| Marketable Securities | 31,065 | 44,779 | 50,872 | 57,710 | 35,417 |
| Receivables | 9,499 | 11,717 | 7,784 | 9,512 | 6,301 |
| Inventories | 4,756 | 4,832 | 3,808 | 3,421 | 3,331 |
| TOTAL | $160,524 | $114,390 | $125,140 | $140,498 | $93,082 |
| Non-Current Assets | |||||
| PPE Net | 1,777 | 1,967 | 1,978 | 2,001 | 2,142 |
| Investments And Advances | 674 | 675 | 4,071 | 8,290 | 0 |
| Other Non-Current Assets | 2,740 | 2,714 | 3,414 | 2,979 | 2,190 |
| TOTAL | $5,191 | $5,356 | $9,463 | $13,270 | $4,332 |
| Total Assets | $165,715 | $119,746 | $134,603 | $153,768 | $97,414 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,936 | 12,102 | 11,062 | 10,342 | 10,558 |
| Accrued Expenses | 5,146 | 6,948 | 6,476 | 6,773 | 4,712 |
| Other current liabilities | 4,009 | 3,330 | 2,268 | 1,941 | 1,735 |
| TOTAL | $19,091 | $22,380 | $19,806 | $19,056 | $17,005 |
| Non-Current Liabilities | |||||
| Long Term Debt | 70,797 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 92,901 | 88,953 | 83,260 | 78,441 | 3,918 |
| TOTAL | $163,698 | $88,953 | $83,260 | $78,441 | $3,918 |
| Total Liabilities | $182,789 | $111,333 | $103,066 | $97,497 | $20,923 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,693 | 22,668 | 22,420 | 22,363 | 22,280 |
| Common Shares | 62 | 61 | 61 | 61 | 61 |
| Retained earnings | -495,713 | -467,321 | -438,869 | -408,658 | -382,436 |
| Other shareholders' equity | -69 | -25 | 4 | 45 | 143 |
| TOTAL | $-17,074 | $8,413 | $31,537 | $56,271 | $76,491 |
| Total Liabilities And Equity | $165,715 | $119,746 | $134,603 | $153,768 | $97,414 |